Tianjin Medical University General Hospital

This study aimed to test the drug eculizumab for treating sudden attacks of neuromyelitis optica spectrum disorder (NMOSD) in adults who test positive for a specific antibody. The goal was to see if the drug could quickly reduce disability by blocking harmful immune system activi…

This study tests whether tocilizumab can safely prevent relapses in people with MOGAD, a rare autoimmune disease that attacks the nervous system. About 102 participants aged 12 and older with recent relapses will receive the drug or a placebo. The goal is to see if the drug delay…